Regenerative Biotechnology
Gencell® Allogeneic Fibroblasts
Placenta-derived allogeneic fibroblasts for skin rejuvenation.
Injectable solution of placenta-derived allogeneic fibroblasts indicated for facial rejuvenation procedures through subdermal application, designed to restore structure, function, and overall quality of aging skin.
Composition
Placenta-derived allogeneic fibroblasts.
Pharmaceutical form
Injectable solution.
Presentation
Single-dose vial, 4 ml.
Therapeutic properties
Promotes skin repair through cellular migration, release of regenerative cytokines, inhibition of metalloproteinases, stimulation of dermal fibroblasts, and increased collagen production, extracellular matrix density, skin thickness, and vascularization.
- Improves skin texture.
- Reduces visible wrinkles.
- Enhances skin firmness.
- Improves skin elasticity.
- Stimulates collagen production.
- Supports tissue regeneration.
- Inhibits extracellular matrix degradation.
- Contributes to a more youthful appearance.
Mechanism of action & Clinical data
Migrates to sites of skin damage, releases regenerative cytokines, inhibits metalloproteinases, and stimulates dermal fibroblasts, promoting tissue repair and structural restoration of the skin.